Chang Chen, Huang Shih-Wen, Su Ih-Jen, Chang Kung-Chao
Department of Pathology.
Leuk Lymphoma. 2014 May;55(5):1023-30. doi: 10.3109/10428194.2013.831849. Epub 2013 Sep 5.
Abstract The World Health Organization (WHO) lymphoma classification has been widely adopted by hematopathologists. However, its practical application by general pathologists is largely unknown. Using a hematopathology consultation program in Taiwan, we reviewed 406 cases. Diagnostic discrepancies were scored based upon whether the divergence would alter disease management according to National Comprehensive Cancer Network guidelines. Major discrepancies accounted for 55% (222/406), minor discrepancies for 5% (20/406) and agreement for 40% (164/406) cases. The more common groups in major discrepancies were non-diagnostic/ambiguous referral reports (116/222, 52%), tumor type revisions (52/222, 23%) and changes from malignant to benign lesions (32/222, 14%). In a total of 259 cases of lymphoma, the concordance rates were 41% (77/187) and 33% (24/72) for B-cell and T/natural killer (NK)-cell lymphomas, respectively. It appears that the WHO approach has made lymphoma classification rather poorly reproducible at least in countries where extensive use of an ancillary technique is not employed by general pathologists.
摘要 世界卫生组织(WHO)淋巴瘤分类已被血液病理学家广泛采用。然而,普通病理学家对其实际应用情况却知之甚少。利用台湾的一个血液病理学咨询项目,我们回顾了406例病例。根据诊断差异是否会根据美国国立综合癌症网络指南改变疾病管理来进行评分。主要差异占55%(222/406),次要差异占5%(20/406),一致率为40%(164/406)。主要差异中较常见的类别为非诊断性/不明确的转诊报告(116/222,52%)、肿瘤类型修订(52/222,23%)以及从恶性病变变为良性病变(32/222,14%)。在总共259例淋巴瘤病例中,B细胞淋巴瘤和T/自然杀伤(NK)细胞淋巴瘤的一致率分别为41%(77/187)和33%(24/72)。看来,至少在普通病理学家未广泛使用辅助技术的国家,WHO的方法使得淋巴瘤分类的可重复性相当差。